Mulmit

Actinium Pharmaceuticals, Inc.Actinium Pharmaceuticals, Inc.

ATNM NYSE

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-08-18SETH SANDESHChief Executive Officer120,900
2025-03-31Steinhart Richard I2,500
2025-03-31Steinhart Richard I2,500
2025-03-31Steinhart Richard I2,500
2025-03-31Steinhart Richard I8,333
2025-03-31Steinhart Richard I8,333
2025-03-31Steinhart Richard I18,351
2025-03-31Steinhart Richard I72,156
2025-03-31Steinhart Richard I70,311
2025-03-31Chell Jeffrey W.2,500
2025-03-31Chell Jeffrey W.2,500
2025-03-31Chell Jeffrey W.8,333

8-K events

FiledItems
2026-08-14Delisting or listing-standard notice · Regulation FD disclosure · Financial statements and exhibits
2026-06-18Other events
2026-05-29Delisting or listing-standard notice · Regulation FD disclosure · Financial statements and exhibits
2026-03-26Submission of matters to a vote
2026-02-13Officer or director change
2025-11-26Officer or director change · Submission of matters to a vote
2025-05-09Change in certifying accountant · Financial statements and exhibits
2024-11-27Officer or director change · Submission of matters to a vote
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…